Results 221 to 230 of about 30,845 (250)

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Safety evaluation of the food enzyme endo-1,4-β-xylanase from the non-genetically modified <i>Trichoderma citrinoviride</i> strain TCLSC. [PDF]

open access: yesEFSA J
EFSA Panel on Food Enzymes (FEZ)   +17 more
europepmc   +1 more source

Safety evaluation of the food enzyme containing metalloendopeptidase and leucyl aminopeptidase activities from the non-genetically modified <i>Aspergillus oryzae</i> strain HBI-POP01. [PDF]

open access: yesEFSA J
EFSA Panel on Food Enzymes (FEZ)   +19 more
europepmc   +1 more source

An inpatient Serious Illness Care Program for older patients with hematologic malignancies: a single-arm pilot study. [PDF]

open access: yesBlood Adv
LoCastro M   +17 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy